Page last updated: 2024-12-06
levetimide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
levetimide: inactive enantiomer of dexetimide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 30844 |
| CHEMBL ID | 273974 |
| SCHEMBL ID | 1651291 |
| MeSH ID | M0070267 |
Synonyms (35)
| Synonym |
|---|
| (3r)-3-phenyl-3-[1-(phenylmethyl)piperidin-4-yl]piperidine-2,6-dione |
| gtpl358 |
| PDSP2_001817 |
| laevo-benzetimide |
| (-)-benzetimide |
| brn 6490018 |
| l-benzetimide |
| levetimide |
| glutarimide, 2-(1-benzyl-4-piperidyl)-2-phenyl-, (-)- |
| (3,4'-bipiperidine)-2,6-dione, 3-phenyl-1'-(phenylmethyl)-, (r)- |
| PDSP1_001834 |
| (3r)-3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione |
| chembl273974 |
| 1''-benzyl-3-phenyl-[3,4'']bipiperidinyl-2,6-dione |
| bdbm50018550 |
| 21888-99-3 |
| 576087i4xg , |
| unii-576087i4xg |
| SCHEMBL1651291 |
| benzetimide, (r)- |
| (3,4'-bipiperidine)-2,6-dione, 3-phenyl-1'-(phenylmethyl)-, (3r)- |
| 5,6-diamino-2,4-dihydroxypyrimidinesulfatedihydrate |
| Q27080260 |
| (r)-1'-benzyl-3-phenyl-[3,4'-bipiperidine]-2,6-dione |
| HY-105545A |
| CS-0068505 |
| r(-)-levetimide hydrochloride (r47210) m usacarin |
| MS-25763 |
| [3,4'-bipiperidine]-2,6-dione, 3-phenyl-1'-(phenylmethyl)-, (3r)- |
| r(-)-levetimidehydrochloride(r47210)musacarin |
| (s)-1'-benzyl-3-phenyl-[3,4'-bipiperidine]-2,6-dione |
| A937280 |
| (3r)-3-phenyl-1'-(phenylmethyl)[3,4'-bipiperidine]-2,6-dione |
| DTXSID401183493 |
| AKOS040741945 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1345364 | Rat M2 receptor (Acetylcholine receptors (muscarinic)) | 1998 | The Journal of pharmacology and experimental therapeutics, Feb, Volume: 284, Issue:2 | Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line. |
| AID1345326 | Human M2 receptor (Acetylcholine receptors (muscarinic)) | 1998 | The Journal of pharmacology and experimental therapeutics, Feb, Volume: 284, Issue:2 | Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.09
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.09) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||